You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output.
Click here to find out more.
X Demographics
Mendeley readers
Attention Score in Context
| Title |
NeuroEPO plus (NeuralCIM®) in mild-to-moderate Alzheimer’s clinical syndrome: the ATHENEA randomized clinical trial
|
|---|---|
| Published in |
Alzheimer's Research & Therapy, December 2023
|
| DOI | 10.1186/s13195-023-01356-w |
| Pubmed ID | |
| Authors |
Saily Sosa, Giosmany Bringas, Nelky Urrutia, Ana Ivis Peñalver, Danay López, Evelio González, Ana Fernández, Zenaida Milagros Hernández, Ariel Viña, Yamile Peña, Juan Felipe Batista, Carmen Valenzuela, Kalet León, Tania Crombet, Teresita Rodríguez, Leslie Pérez |
X Demographics
The data shown below were collected from the profiles of 158 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Cuba | 25 | 16% |
| Venezuela, Bolivarian Republic of | 4 | 3% |
| United States | 2 | 1% |
| Spain | 2 | 1% |
| Japan | 1 | <1% |
| United Kingdom | 1 | <1% |
| Dominican Republic | 1 | <1% |
| Panama | 1 | <1% |
| Unknown | 121 | 77% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 157 | 99% |
| Scientists | 1 | <1% |
Mendeley readers
The data shown below were compiled from readership statistics for 5 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Unknown | 5 | 100% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Unspecified | 1 | 20% |
| Researcher | 1 | 20% |
| Unknown | 3 | 60% |
| Readers by discipline | Count | As % |
|---|---|---|
| Unspecified | 1 | 20% |
| Pharmacology, Toxicology and Pharmaceutical Science | 1 | 20% |
| Materials Science | 1 | 20% |
| Unknown | 2 | 40% |
Attention Score in Context
This research output has an Altmetric Attention Score of 145. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 25 April 2024.
All research outputs
#292,624
of 25,866,425 outputs
Outputs from Alzheimer's Research & Therapy
#47
of 1,515 outputs
Outputs of similar age
#4,566
of 365,902 outputs
Outputs of similar age from Alzheimer's Research & Therapy
#2
of 51 outputs
Altmetric has tracked 25,866,425 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 98th percentile: it's in the top 5% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 1,515 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 26.5. This one has done particularly well, scoring higher than 96% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 365,902 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 98% of its contemporaries.
We're also able to compare this research output to 51 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 96% of its contemporaries.